Table 2 Characteristics and genetic substrate of carriers (patients and controls) with heterozygous dominant or homozygous recessive variants

From: The genetic architecture of Parkinson’s disease on the Island of Crete

ID

Group

Age at onset (y)

Sex

Age at enrollment (y)

Ethnicity

Pathogenic/Likely pathogenic

VUS

#P001

sLOPD

60.6

Male

63.3

Greek

NA

GBA1:p.T408M

#P006

sLOPD

64.1

Male

66.8

Greek

GBA1:p.N409S; ATP13A2:p.T517I; PLA2G6:p.D739H

NA

#P008

sLOPD

63.6

Male

71.1

Greek

NA

GCH1:p.E2G

#P011

fPD

41.4

Female

72.6

Greek

LRRK2:p.G2019S

NA

#P014

fPD

68.0

Female

75.3

Greek

PRKN:p.R275W

GCH1:p.E2G

#P038

sEOPD

38.7

Male

46.2

Greek

GBA1:p.L483P

NA

#P039

fPD

71.4

Female

79.8

Greek

NA

GBA1:p.T408M;

GCH1:p.Q48K

#P041

sLOPD

60.4

Male

66.0

Greek

NA

SORL1:p.G1379D

#P059

sLOPD

55.2

Female

57.9

Greek

NA

GCH1:p.Q48K

#P063

sLOPD

71.6

Male

84.3

Greek

NA

DNAJC13:p.E843G

#P064

sLOPD

60.5

Male

71.5

Greek

NA

LRRK2:p.L119P

#P072

sLOPD

62.6

Female

55.1

Greek

GBA1:p.L483P

NA

#P074

sLOPD

84.5

Male

86.8

Greek

NA

GIGYF2:p.S335T;

PLA2G6:p.D183N

#P078

sLOPD

59.9

Male

54.2

Greek

GBA1:p.L483P

NA

#P081

sEOPD

44.5

Female

54.0

Greek

FIG4:p.I41Ta

POLG:p.A219S

#P084

sLOPD

54.8

Male

59.4

Greek

GBA1:p.L483P

NA

#P092

fPD

58.5

Male

70.6

Greek

NA

GBA1:p.T408M;

PLA2G6:p.S258L

#P093

sLOPD

54.3

Female

54.7

Greek

GBA1:p.L483P

NA

#P100

fPD

44.8

Male

60.4

Greek

NA

GCH1:p.Q48K

#P104

sEOPD

41.9

Female

42.6

Greek

GBA1:p.L483P; GCH1:p.T94M

NA

#P105

sLOPD

67.2

Female

68.9

Greek

NA

SORL1:p.V1616L

#P114

sLOPD

58.7

Female

63.7

Greek

NA

GBA1:p.E365K

#P132

sEOPD

49.1

Female

55.5

Greek

NA

GBA1:p.E365K

#P135

fPD

43.0

Male

45.3

Greek

NA

GBA1:p.T408M;

POLG:p.V1044A

#P137

sLOPD

67.3

Female

81.3

Greek

GBA1:p.L483P

NA

#P145

sEOPD

50.4

Female

50.4

Greek

NA

GBA1:p.E365K

#P161

sLOPD

53.6

Male

74.5

Greek

NA

GCH1:p.E2G

#P165

sLOPD

61.9

Female

70.8

Greek

NA

GCH1:p.Q48K

#P171

sLOPD

62.2

Male

73.1

Greek

NA

LRP10:p.R151H

#P177

fPD

51.5

Female

57.0

Greek

NA

GBA1:p.T408M

#P188

sLOPD

54.9

Female

56.2

non-Greek

NA

GBA1:p.E365K

#P195

fPD

51.7

Female

57.8

Greek

NA

GBA1:p.T408M

#P196

sLOPD

59.6

Female

61.6

Greek

SNCA:p.A53T

NA

#P208

sLOPD

51.0

Female

54.0

Greek

NA

GBA1:p.R502H

#P211

fPD

62.7

Female

76.0

Greek

GBA1:p.N409S

NA

#P212

sLOPD

64.3

Male

72.2

Greek

PNPLA6:p.R1311W; GCH1:p.T94Ma

GCH1:p.Q48K

#P217

sLOPD

64.3

Male

79.0

Greek

NA

GCH1:p.E2G;

PARK7:p.A107T

#P219

sLOPD

52.6

Male

52.6

Greek

NA

GBA1:p.T408M;

PINK1:p.R152W

#P221

fPD

34.2

Male

43.0

Greek

PINK1:p.Y295Tera

NA

#P224

sLOPD

63.0

Male

63.0

non-Greek

NA

CHCHD2:p.G4R;

PINK1:p.G32R

#P229

sEOPD

38.4

Male

44.6

non-Greek

NA

GBA1:p.E365K

#P230

fPD

54.1

Male

54.3

Greek

GBA1:p.L483P; ATP13A2:p.T517I

ATP13A2:p.R545C

#P240

sLOPD

72.9

Female

72.9

Greek

NA

GCH1:p.E2G

#P245

fPD

62.7

Male

62.7

Greek

LRRK2:p.G2019S; POLG:p.P587L

NA

#P261

sLOPD

69.7

Female

72.1

Greek

NA

GBA1:p.T408M

#P263

fPD

60.1

Male

63.5

Greek

GBA1:p.L483P

NA

#P265

sLOPD

55.6

Male

70.3

non-Greek

NA

DNAJC13:p.E1659A

#P274

fPD

50.6

Female

50.6

non-Greek

GBA1:p.D448H; GBA1:p.H294Q

NA

#P278

sLOPD

65.1

Female

71.9

Greek

GCH1:p.C18Ter; GCH1:p.T94M

NA

#P288

sEOPD

47.6

Male

63.4

Greek

NA

DNAJC6:p.H606P;

GBA1:p.K237T

#P297

sEOPD

48.2

Male

57.0

non-Greek

NA

LRP10:p.Y307N;

PRKN:p.M192V

#P301

fPD

58.0

Male

82.2

Greek

NA

GCH1:p.Q48K

#P304

sEOPD

48.0

Female

48.0

Greek

GCH1:p.M1?

SPG7:p.A10S

#P323

sLOPD

80.8

Male

80.8

Greek

ATP13A2:p.T517I; LRRK2:p.G2019S

NA

#P336

fPD

70.0

Male

73.8

Greek

GCH1:p.M1?;

PNPLA6:p.W911Ter; GCH1:p.T94M

NA

#P343

fPD

39.0

Male

47.0

Greek

NA

LRRK2:p.L119P;

SPG7:p.A10T

#P345

fPD

40.6

Female

40.6

Greek

PRKN:p.R42P

GCH1:p.Q48K

#P347

sLOPD

63.8

Male

64.0

Greek

NA

GBA1:p.T408M; GIGYF2:p.S335T

#P350

sEOPD

35.0

Female

35.0

Greek

NA

GCH1:p.Q48K

#P360

sEOPD

50.0

Male

50.0

Greek

NA

GBA1:p.T408M

#P367

sEOPD

45.5

Male

71.5

Greek

NA

GBA1:p.E365K

#P369

fPD

60.0

Male

60.0

Greek

GBA1:p.L483P; PINK1:p.F385L

POLG:p.R1034K

#P372

fPD

62.0

Male

62.0

Greek

LRRK2:p.R1441H

NA

#P374

fPD

57.0

Male

67.0

Greek

GBA1:p.H294Q

NA

#P375

fPD

60.0

Female

60.0

Greek

NA

GBA1:p.C55S

#P393

sLOPD

68.0

Female

61.0

Greek

GBA1:p.L483P

NA

#P394

sLOPD

63.9

Male

65.4

Greek

NA

GBA1:p.E365K

#P397

sEOPD

47.2

Male

55.5

Greek

NA

GBA1:p.E365K

#P407

fPD

54.0

Female

55.7

Greek

NA

GBA1:p.T408Ma

#P408

sLOPD

70.8

Female

74.2

Greek

NA

VPS35:p.A737V

#C053

Control

NA

Male

65.0

Greek

NA

LRRK2:p.L119P

#C080

Control

NA

Male

63.0

Greek

NA

VPS35:p.A737V

#C081

Control

NA

Male

65.0

Greek

NA

ATXN2:p.P794S

#C093

Control

NA

Male

71.7

Greek

NA

LRRK2:p.L119P

#C099

Control

NA

Male

64.0

Greek

NA

ATXN2:p.P794S

#C104

Control

NA

Male

70.0

Greek

NA

POLG:p.V1044Aa

#C115

Control

NA

Female

74.4

Greek

NA

GBA1:p.T408M

#C127

Control

NA

Male

79.7

Greek

NA

LRRK2:p.L119P

#C128

Control

NA

Male

68.8

Greek

NA

GBA1:p.T408M

#C151

Control

NA

Female

61.4

Greek

NA

LRP10:p.R151H

#C169

Control

NA

Male

60.7

Greek

NA

GBA1:p.E365K

#C174

Control

NA

Male

62.0

Greek

NA

GBA1:p.E365K

#C214

Control

NA

Male

76.0

Greek

NA

LRRK2:p.L119P

#C258

Control

NA

Male

62.0

Greek

NA

LRRK2:p.T2356I

#C263

Control

NA

Male

75.0

Greek

NA

LRRK2:p.R493C

#C270

Control

NA

Female

73.8

Greek

NA

LRRK2:p.L119P

#C310

Control

NA

Male

67.0

Greek

NA

ATXN2:p.P794S

  1. fPD familial Parkinson’s disease, NA non-applicable, sEOPD sporadic early-onset Parkinson’s disease, sLOPD sporadic late-onset Parkinson’s disease, VUS variants of uncertain significance, y years
  2. aHomozygosity for this variant.